PTC Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on PTC Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how PTC Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with PTC Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
PTC Therapeutics Inc (PTC) is a biopharmaceutical company. Lead products such as translarna and emflaza, focused R&D activities, and proprietary technologies are its strengths; declining net product revenue remains a major cause for concern to the company. PTC could benefit from the orphan drug designation, regulatory approvals, and positive outlook of the global pharmaceutical market. However, dependence on third-party manufacturers, stiff competition, and stringent pricing pressures in the US could hamper its growth.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer